{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:24:51Z","timestamp":1786991091909,"version":"build-2736575974"},"reference-count":44,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T00:00:00Z","timestamp":1786924800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Nirsevimab and the maternal vaccination in pregnancy are newly introduced prevention strategies against respiratory syncytial virus (RSV). This study evaluated pediatricians\u2019 knowledge, attitudes, and barriers to RSV immunization in Italy and Cyprus\/Greece, where nirsevimab had not yet been implemented, and in Spain, where it was introduced in 2023\/2024.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A survey was distributed to pediatricians across Spain, Italy, and Cyprus\/Greece in July-August\/2024. Occupational characteristics, and knowledge, attitudes and practices toward palivizumab, nirsevimab, and the maternal vaccine were collected. Of 578 respondents (response rate\u2009=\u200919.3%), 50% were from Spain, 40% from Italy, and 10% from Cyprus\/Greece. As 90% of responses came from Spain and Italy, the main analysis focused on these two countries. Descriptive and univariate analyses (Chi-square or Fisher\u2019s exact tests) were conducted.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Respondents included pediatricians from community (51.7%), tertiary (30.4%), and primary\/secondary care (17.9%) settings. Pediatricians were generally aware of RSV risk factors, without differences across countries. However, 245 (55.9%) and 375 (86.0%) participants reported average-to-low knowledge of nirsevimab and the maternal vaccine, respectively, with differences across countries (p\u2009=\u20090.002). Despite limited knowledge, 311 (85.9%) pediatricians were willing to administer nirsevimab, and 319 (92.2%) supported its use for all infants. Nirsevimab administration\u2019s barriers, including unfamiliarity and logistical challenges, were cited by 69 (20.0%) pediatricians. Regarding immunization preferences, 165 (47.4%) pediatricians were very likely to support the maternal vaccine over nirsevimab.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec004\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>While pediatricians support RSV immunization, knowledge gaps and logistical barriers may hinder early-stage implementation. Optimizing education on RSV immunization will be crucial to improve uptake and prevention strategies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pone.0356233","type":"journal-article","created":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:25:01Z","timestamp":1786987501000},"page":"e0356233","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pediatricians\u2019 attitudes and knowledge of RSV immunization products: A multi-country cross-sectional survey"],"prefix":"10.1371","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3586-0612","authenticated-orcid":true,"given":"Costanza","family":"Di Chiara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Philippe","family":"Pich\u00e9-Renaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-5657-4589","authenticated-orcid":true,"given":"Vera","family":"Rigamonti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Cantarutti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Calvo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Rivero Calle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9613-7228","authenticated-orcid":true,"given":"Antoni","family":"Soriano-Arandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Giaquinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Cantarutti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Don\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Lo Vecchio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adamos","family":"Hadjipanayis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoi Dorothea","family":"Pana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis","family":"Kopsidas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-1200-992X","authenticated-orcid":true,"given":"Adria","family":"Rose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo","family":"Tagarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9809-0822","authenticated-orcid":true,"given":"Shaun K.","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,8,17]]},"reference":[{"issue":"10098","key":"pone.0356233.ref001","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/S0140-6736(17)30938-8","article-title":"Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study","volume":"390","author":"T Shi","year":"2017","journal-title":"Lancet"},{"issue":"9","key":"pone.0356233.ref002","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1056\/NEJMoa1405870","article-title":"Community-acquired pneumonia requiring hospitalization among U.S. children","volume":"372","author":"S Jain","year":"2015","journal-title":"N Engl J Med"},{"issue":"5","key":"pone.0356233.ref003","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/QCO.0000000000000952","article-title":"The disease burden of respiratory syncytial virus in Infants","volume":"36","author":"APS Munro","year":"2023","journal-title":"Curr Opin Infect Dis"},{"key":"pone.0356233.ref004","unstructured":"Centers for Disease Control and Prevention. Respiratory syncytial virus infection (RSV): RSV in infants and young children; 2020. Available from: https:\/\/www.cdc.gov\/rsv\/index.html"},{"issue":"2","key":"pone.0356233.ref005","article-title":"Respiratory syncytial virus-associated hospitalizations among children less than 24 months of age","volume":"132","author":"CB Hall","year":"2013","journal-title":"Pediatrics"},{"issue":"5","key":"pone.0356233.ref006","article-title":"Cost-effectiveness of palivizumab for respiratory syncytial virus: a systematic review","volume":"143","author":"S Mac","year":"2019","journal-title":"Pediatrics"},{"issue":"9","key":"pone.0356233.ref007","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1080\/21645515.2017.1337614","article-title":"Product review on the monoclonal antibody palivizumab for prevention of respiratory syncytial virus infection","volume":"13","author":"B Resch","year":"2017","journal-title":"Hum Vaccin Immunother"},{"issue":"9","key":"pone.0356233.ref008","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1056\/NEJMoa2110275","article-title":"Nirsevimab for prevention of RSV in healthy late-preterm and term infants","volume":"386","author":"LL Hammitt","year":"2022","journal-title":"N Engl J Med"},{"issue":"5","key":"pone.0356233.ref009","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1056\/NEJMoa1913556","article-title":"Single-dose nirsevimab for prevention of RSV in preterm infants","volume":"383","author":"MP Griffin","year":"2020","journal-title":"N Engl J Med"},{"issue":"9","key":"pone.0356233.ref010","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1136\/archdischild-2024-327153","article-title":"Effectiveness of nirsevimab immunoprophylaxis against respiratory syncytial virus-related outcomes in hospital and primary care settings: a retrospective cohort study in infants in Catalonia (Spain)","volume":"109","author":"E Coma","year":"2024","journal-title":"Arch Dis Child"},{"issue":"6","key":"pone.0356233.ref011","doi-asserted-by":"crossref","first-page":"2400046","DOI":"10.2807\/1560-7917.ES.2024.29.6.2400046","article-title":"Early estimates of nirsevimab immunoprophylaxis effectiveness against hospital admission for respiratory syncytial virus lower respiratory tract infections in infants, Spain, October 2023 to January 2024","volume":"29","author":"M L\u00f3pez-Lacort","year":"2024","journal-title":"Euro Surveill"},{"issue":"8","key":"pone.0356233.ref012","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S1473-3099(24)00215-9","article-title":"Effectiveness and impact of universal prophylaxis with nirsevimab in infants against hospitalisation for respiratory syncytial virus in Galicia, Spain: initial results of a population-based longitudinal study","volume":"24","author":"S Ares-G\u00f3mez","year":"2024","journal-title":"Lancet Infect Dis"},{"issue":"10","key":"pone.0356233.ref013","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/S2352-4642(24)00171-8","article-title":"Real-world effectiveness of nirsevimab immunisation against bronchiolitis in infants: a case-control study in Paris, France","volume":"8","author":"R Carbajal","year":"2024","journal-title":"Lancet Child Adolesc Health"},{"key":"pone.0356233.ref014","doi-asserted-by":"crossref","first-page":"101007","DOI":"10.1016\/j.lanepe.2024.101007","article-title":"Effectiveness of nirsevimab against RSV-bronchiolitis in paediatric ambulatory care: a test-negative case-control study","volume":"44","author":"Y Lassoued","year":"2024","journal-title":"Lancet Reg Health Eur"},{"key":"pone.0356233.ref015","article-title":"Respiratory syncytial virus disease burden and nirsevimab effectiveness in young children from 2023-2024","author":"AP Toepfer","year":"2024","journal-title":"JAMA Pediatr"},{"key":"pone.0356233.ref016","article-title":"Real-world effectiveness of nirsevimab against respiratory syncytial virus: a test-negative case-control study","author":"H Xu","year":"2024","journal-title":"medRxiv"},{"issue":"1","key":"pone.0356233.ref017","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2024-066393","article-title":"Nirsevimab effectiveness against severe respiratory syncytial virus infection in the primary care setting","volume":"155","author":"M L\u00f3pez-Lacort","year":"2025","journal-title":"Pediatrics"},{"key":"pone.0356233.ref018","article-title":"Respiratory syncytial virus disease burden and nirsevimab effectiveness in young children from 2023-2024","author":"HL Moline","year":"2024","journal-title":"JAMA Pediatr"},{"issue":"16","key":"pone.0356233.ref019","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJMoa2216480","article-title":"Bivalent prefusion F vaccine in pregnancy to prevent RSV illness in infants","volume":"388","author":"B Kampmann","year":"2023","journal-title":"N Engl J Med"},{"issue":"6","key":"pone.0356233.ref020","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/s41390-021-01804-z","article-title":"Pediatrician\u2019s role in vaccinating children and families for COVID-19: no one left behind","volume":"90","author":"A de St Maurice","year":"2021","journal-title":"Pediatr Res"},{"issue":"3","key":"pone.0356233.ref021","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1177\/1090198118819716","article-title":"Vaccine information sources and parental trust in their child\u2019s health care provider","volume":"46","author":"NM Eller","year":"2019","journal-title":"Health Educ Behav"},{"key":"pone.0356233.ref022","article-title":"Sources and perceived credibility of vaccine-safety information for parents","author":"GL Freed","year":"2011","journal-title":"Pediatrics"},{"issue":"5","key":"pone.0356233.ref023","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2006-0923","article-title":"Association between health care providers\u2019 influence on parents who have concerns about vaccine safety and vaccination coverage","volume":"118","author":"PJ Smith","year":"2006","journal-title":"Pediatrics"},{"issue":"4","key":"pone.0356233.ref024","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1542\/peds.2007-0538","article-title":"Parents with doubts about vaccines: which vaccines and reasons why","volume":"122","author":"DA Gust","year":"2008","journal-title":"Pediatrics"},{"issue":"3","key":"pone.0356233.ref025","article-title":"Strategies for improving vaccine communication and uptake","volume":"153","author":"Committee on Infectious Diseases, Committee on Practice and Ambulatory Medicine","year":"2024","journal-title":"Pediatrics"},{"issue":"1","key":"pone.0356233.ref026","first-page":"34","article-title":"Immunisation schedule of the Spanish Association of Pediatrics: 2024 recommendations","volume":"100","author":"FJ \u00c1lvarez Garc\u00eda","year":"2024","journal-title":"An Pediatr (Engl Ed)"},{"key":"pone.0356233.ref027","unstructured":"Ministerio De Sanidad. Vacunas y Programa de Vacunaci\u00f3n. Enfermedad por Virus Respiratorio Sincitial (VRS). Available from: https:\/\/www.sanidad.gob.es\/areas\/promocionPrevencion\/vacunaciones\/comoTrabajamos\/sincitial.htm"},{"key":"pone.0356233.ref028","unstructured":"Vaccinazione contro il virus respiratorio sinciziale in gravidanza. Position paper of the Italian AGOI, AIO, SIGO, FNOPO, SIMP, SIn and SIP societies; 2024 [cited 2025 Jan 13]. Available (in Italian only) from: https:\/\/sip.it\/wp-content\/uploads\/2024\/03\/position-paper-VRS-.pdf"},{"key":"pone.0356233.ref029","unstructured":"CDC RSVVaxView, Kang Y, Zhang F, Vogt TM. Pediatrician and OB\/GYN Survey on RSV Immunization; 2024 [cited 2024 Dec 9]. Available from: https:\/\/www.cdc.gov\/rsvvaxview\/publications\/rsv-immunization-survey-2024.html"},{"issue":"1","key":"pone.0356233.ref030","doi-asserted-by":"crossref","first-page":"154","DOI":"10.3390\/pediatric15010013","article-title":"Respiratory syncytial virus prevention through monoclonal antibodies: a cross-sectional study on knowledge, attitudes, and practices of Italian pediatricians","volume":"15","author":"M Ricc\u00f2","year":"2023","journal-title":"Pediatr Rep"},{"key":"pone.0356233.ref031","unstructured":"Jones J. Evidence to recommendations framework: nirsevimab updates. Presentation to ACIP 2023. Available from: https:\/\/www.cdc.gov\/vaccines\/acip\/meetings\/downloads\/slides-2023-08-3\/02-RSV-jones-508.pdf"},{"issue":"15","key":"pone.0356233.ref032","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.3390\/healthcare12151536","article-title":"Assessment of knowledge, attitudes, and vaccination practices regarding the new RSV vaccine among health professionals in Greece","volume":"12","author":"D Papagiannis","year":"2024","journal-title":"Healthcare (Basel)"},{"issue":"1","key":"pone.0356233.ref033","doi-asserted-by":"crossref","first-page":"15838","DOI":"10.1038\/s41598-025-01021-2","article-title":"Knowledge, attitudes, and practices of Croatian pediatricians and pediatrics residents about RSV infection","volume":"15","author":"D Mrcela","year":"2025","journal-title":"Sci Rep"},{"issue":"1","key":"pone.0356233.ref034","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s13052-024-01593-1","article-title":"Knowledge, attitudes and behaviours of a sample of Italian paediatricians towards RSV and its preventive strategies: a cross-sectional study","volume":"50","author":"G Congedo","year":"2024","journal-title":"Ital J Pediatr"},{"issue":"1","key":"pone.0356233.ref035","doi-asserted-by":"crossref","first-page":"2498264","DOI":"10.1080\/21645515.2025.2498264","article-title":"Assessment of physicians\u2019 perception of pediatrics respiratory syncytial virus disease and preferences for immunization strategies in the United States","volume":"21","author":"Y Choi","year":"2025","journal-title":"Hum Vaccin Immunother"},{"issue":"2","key":"pone.0356233.ref036","doi-asserted-by":"crossref","first-page":"153","DOI":"10.24953\/turkjpediatr.2025.5528","article-title":"Turkish pediatricians\u2019 knowledge, attitudes, and awareness of respiratory syncytial virus (RSV) infection and immunization strategies: a cross-sectional study","volume":"67","author":"\u0130 Y\u0131ld\u0131z","year":"2025","journal-title":"Turk J Pediatr"},{"issue":"38","key":"pone.0356233.ref037","doi-asserted-by":"crossref","first-page":"837","DOI":"10.15585\/mmwr.mm7338a2","article-title":"Maternal respiratory syncytial virus vaccination and receipt of respiratory syncytial virus antibody (nirsevimab) by infants aged <8 months - United States, April 2024","volume":"73","author":"H Razzaghi","year":"2024","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"3","key":"pone.0356233.ref038","doi-asserted-by":"crossref","DOI":"10.1542\/hpeds.2023-007639","article-title":"Early experiences with nirsevimab: perspectives from newborn hospitalists","volume":"14","author":"E Aragona","year":"2024","journal-title":"Hosp Pediatr"},{"issue":"12","key":"pone.0356233.ref039","doi-asserted-by":"crossref","DOI":"10.1542\/hpeds.2024-007911","article-title":"Nirsevimab administration during the birth hospitalization","volume":"14","author":"S Daneshvari","year":"2024","journal-title":"Hosp Pediatr"},{"issue":"4","key":"pone.0356233.ref040","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.acap.2021.10.004","article-title":"Timing of vaccine decision-making among first-time parents","volume":"22","author":"JN Yarnall","year":"2022","journal-title":"Acad Pediatr"},{"issue":"49","key":"pone.0356233.ref041","doi-asserted-by":"crossref","first-page":"2300606","DOI":"10.2807\/1560-7917.ES.2023.28.49.2300606","article-title":"Early lessons from the implementation of universal respiratory syncytial virus prophylaxis in infants with long-acting monoclonal antibodies, Galicia, Spain, September and October 2023","volume":"28","author":"F Martin\u00f3n-Torres","year":"2023","journal-title":"Euro Surveill"},{"issue":"12","key":"pone.0356233.ref042","article-title":"Interventions for improving coverage of childhood immunisation in low- and middle-income countries","volume":"12","author":"A Oyo-Ita","year":"2023","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"pone.0356233.ref043","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1186\/s12889-020-09169-4","article-title":"Barriers to childhood immunization in sub-Saharan Africa: a systematic review","volume":"20","author":"JB Bangura","year":"2020","journal-title":"BMC Public Health"},{"issue":"2","key":"pone.0356233.ref044","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.pcl.2022.11.004","article-title":"Maternal vaccination and vaccine hesitancy","volume":"70","journal-title":"Pediatr Clin North Am"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0356233","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:25:12Z","timestamp":1786987512000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0356233"}},"subtitle":[],"editor":[{"given":"Ricardo Q.","family":"Gurgel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,8,17]]},"references-count":44,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8,17]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0356233","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,17]]}}}